An extensive literature regarding gender differences relevant to several aspects of
schizophrenia is nowadays available. It includes some robust findings as well as some …

The present study aims to provide a critical overview of the literature on the relationships
between post-acute COVID-19 infection and cognitive impairment, highlighting the limitations …

Introduction Negative symptoms in schizophrenia are associated with poor response to
available treatments, poor quality of life, and functional outcome. Therefore, they represent a …

Cognitive dysfunctions represent a core feature of schizophrenia-spectrum disorders due to
their presence throughout different illness stages and their impact on functioning. …

The identification of factors associated with functional outcome of subjects with schizophrenia
is a great challenge in current research oriented to the personalization of care. The Italian …

The 11th revision of the International Classification of Diseases (ICD-11) has come into effect
on January 1, 2022. All the Member States of the World Health Organization (WHO) will …

The integration of pharmacotherapy with psychosocial interventions has an important role to
play in the improvement of functional outcome of subjects with schizophrenia (SCZ), in all …

Introduction In this study we assessed the contribution of psychopathology, including the
two domains of negative symptoms (motivational deficit and expressive deficit), processing …

BackgroundThe structure of negative symptoms of schizophrenia is still a matter of controversy.
Although a two-dimensional model (comprising the expressive deficit dimension and the …

Deficit schizophrenia is a subtype of schizophrenia presenting primary and enduring negative
symptoms (NS). Although one of the most updated hypotheses indicates a relationship …